MGlu5 antagonism impairs exploration and memory of spatial and non-spatial stimuli in rats

Behavioural Brain Research

Volumn 191, Issue 2, 2008, Pages 235-245

  Christoffersen, Gert R J ^a   Simonyi, Agnes ^b   Schachtman, Todd R ^c   Clausen, Bettina ^a   Clement, David ^a   Bjerre, Vicky K ^a   Mark, Louise T ^a   Reinholdt, Mette ^a   Schmith Rasmussen, Kati ^a   Zink, Lena V B ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Missouri   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Antagonist; Exploration; Maze learning; mGlu5 receptor; MPEP; Object recognition; Prelimbic cortex; Rat

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; GLUTAMATE RECEPTOR ANTAGONIST; METABOTROPIC RECEPTOR 5;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EVALUATION; EXPLORATORY BEHAVIOR; LOCOMOTION; MALE; MAZE TEST; MEMORY DISORDER; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; RECOGNITION; SHORT TERM MEMORY; SPATIAL DISCRIMINATION; SPATIAL MEMORY;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; EXCITATORY AMINO ACID ANTAGONISTS; EXPLORATORY BEHAVIOR; GABA ANTAGONISTS; LOCOMOTION; MALE; MAZE LEARNING; MEMORY DISORDERS; PATTERN RECOGNITION, PHYSIOLOGICAL; PICROTOXIN; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SPACE PERCEPTION; TIME FACTORS;

EID: 43849090366     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.03.032     Document Type: Article

References (49)

1. Anderson J.J., Rao S.P., Rowe B., Giracello D.R., Holtz G., Chapman D.F., et al. [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo charaterization. J Pharmacol Exp Therapeutics 303 (2002) 1044-1051
2. Anwyl R. Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res Rev 29 (1999) 83-120
3. Ballard T.M., Woolley M.L., Prinssen E., Huwyler J., Porter R., and Spooren W. The effect of the mGluR5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison. Psychopharmacology 179 (2005) 218-229
4. Balschun D., Manahan-Vaughan D., Wagner T., Behnish T., Reymann K.G., and Wetzel W. A specific role for group I mGluRs in hippocampal LTP and hippocampus-dependent spatial learning. Learn Mem 6 (1999) 138-152
5. Balschun D., and Wetzel W. Inhibition of mGluR5 blocks hippocampal LTP in vivo and spatial learning in rats. Pharmacol Biochem Behav 73 (2002) 375-380
6. Balschun D., Zuschratter W., and Wetzel W. Allosteric enhacement of metabotropic glutamate receptor 5 function promotes spatial memory. Neuroscience 142 (2006) 691-702
7. Bills C., Schachtman T.R., Spooren W.P.J.M., Gasparini F., and Simonyi A. Effects of metabotropic glutamate receptor 5 on latent inhibition in conditioned taste aversion. Behav Brain Res 157 (2005) 71-78
8. Bradbury M.J., Campbell U., Giracello D., King C., Tehrani L., Cosford N.D., et al. Metabotropic glutamate receptor mGlu5 is a mediator of appetitive and energy balance in rats and mice. J Pharmacol Exp Therapeutics 313 (2005) 395-402
9. Brodkin J., Busse C., Sukoff S.J., and Varney M.A. Anxiolytic-like activity of the mGluR5 antagonist MPEP. A comparison with diazepam and buspirone. Pharmacol Biochem Behav 73 (2002) 359-366
10. Campbell U.C., Lalwani K., Hernandez L., Kinney G.G., Conn P.J., and Bristow L.J. The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats. Psychopharmacology 175 (2004) 310-318
11. Conn P.J., and Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Ann Rev Pharmacol Toxicol 37 (1997) 205-237
12. Cosford N.D., Roppe J., Tehrani L., Schweiger E.J., Seiders T.J., Chaudhary A., et al. [3H]-Methoxymethyl-MTEP and [3H]-methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor. Bioorg Med Chem Lett 10 (2003) 351-354
13. Dember W.N., and Richman C.L. Spontaneous alternation behavior (1989), Springer-Verlag, New York
14. Ennaceur A., and Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1. Behavioural data. Behav Brain Res 31 (1988) 47-59
15. Gasparini F., Lingenhöhl K., Stoehr N., Flor P.J., Heinrich M., Vranesic I., et al. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 38 (1999) 1493-1503
16. Gravius A., Barberi C., Schäfer D., Schmidt W.J., and Danysz W. The role of group I metabotropic glutamate receptors in acquisition and expression of contextual and auditory fear conditioning in rats-a comparison. Neuropharmacology 51 (2006) 1146-1155
17. Gravius A., Pietraszek M., Schäfer D., Schmidt W.J., and Danysz W. Effects of mGlu1 and mGlu5 receptor antagonists on negatively reinforced learning. Behav Pharmacol 16 (2005) 113-121
18. Henry S.A., Lehmann-Masten V., Gasparini F., Geyer M.A., and Markou A. The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity. Neuropharmacology 43 (2002) 1199-1209
19. Hermans E., and Challiss R.A.J. Structural, signaling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein coupled receptors. Biochem J 359 (2001) 465-484
20. Homayoun H., Stefani M.R., Adams B.W., Tamagan G.D., and Moghaddam B. Functional interactions between NMDA and mGluR5 receptors: effects on working memory, instrumental learning, motor behaviours, and dopamine release. Neuropsychopharmacology 29 (2004) 1259-1269
21. Hooper N., Fraser C., and Stone T.V. Effects of purine analogues on spontaneous alternation in mice. Psychopharmacology 123 (1996) 250-257
22. Jay T.M., Thierry A.-M., Wiklund L., and Glowinski J. Excitatory amino acid pathway from hippocampus to the prefrontal cortex. Contribution of AMPA receptors in hippocampo-prefrontal cortex transmission. Eur J Neurosci 4 (1992) 1285-1295
23. Jay T.M., and Witter M.P. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin. J Comp Neurol 313 (1991) 574-586
24. Kinney G.G., Burno M., Campbell U.C., Hernandez L., Rodriguez D., Bristow L.J., et al. Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents. J Pharmacol Exp Therapeutics 306 (2003) 116-123
25. Klodzinska A., Tatarczynska E., Chojnacka-Wojcik E., and Pilc A. Anxiolytic-like effects of a group I metabotropic glutamate antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) in rats. Pol J Pharmacol 52 (2000) 463-466
26. Koros E., Rosenbrock H., Birk G., Weiss C., and Sams-Dodd F. The selective mGlu5 receptor antagonist MTEP, similar to NMDA receptor antagonists, induces social isolation in rats. Neuropsychopharmacology 32 (2007) 562-576
27. Laroche S., Davis S., and Jay T.M. Plasticity at hippocampal to prefrontal cortex synapses: dual roles in working memory and consolidation. Hippocampus 10 (2000) 438-446
28. Manahan-Vaughan D., and Braunewell D. The metabotropic glutamate receptor, mGluR5, is a key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity. Cerebral cortex 11 (2005) 1703-1713
29. McGeehan A.J., Janak P.H., and Olive M.F. Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, d-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice. Psychopharmacology 174 (2004) 266-273
30. Naie K., and Manahan-Vaughan D. Regulation by metabotropic glutamate receptor 5 of LTP in the dentate gyrus of freely moving rats: relevance for learning and memory formation. Cerebral cortex 14 (2004) 189-198
31. Nicolas L.B., Klein S., and Prinssen E.P. Defensive-like behaviors induced by ultrasound: further pharmacological characterization in Lister-hooded rats. Psychopharmacology 194 (2007) 243-252
32. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1988), Academic Press, San Diego, London
33. Petersen S., Bomme C., Baastrup C., Kemp A., and Christoffersen G.R.J. Differential effects of mGluR1- and mGluR5 antagonism on spatial learning in rats. Pharmacol Biochem Behav 73 (2002) 381-389
34. Pietraszek M., Gravius A., Schäfer D., Weil T., Trifanova D., and Danysz W. MGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition. Neuropharmacology 49 (2005) 73-85
35. Pilc A., Klodzinska A., Branski P., Nowak G., Palucha A., Szewczyk B., et al. Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats. Neuropharmacology 43 (2002) 181-187
36. Popik P., and Wrobel M. Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Neuropharmacology 43 (2002) 1210-1217
37. Ragozzino M.E., Unick K.E., and Gold P.E. Hippocampal acetylcholine release during memory testing in rats: augmentation by glucose. Proc Natl Acad Sci USA 93 (1996) 4693-4698
38. Riedel G., Platt B., and Micheau J. Glutamate receptor function in learning and memory. Behav Brain Res 140 (2003) 1-47
39. Schachtman T.R., Bills C., Ghinescu R., Murch K., Serfozo P., and Simonyi A. MPEP, a selective glutamate receptor 5 antagonist, attenuates conditioned taste aversion in rats. Behav Brain Res 141 (2003) 177-182
40. Schulz B., Fendt M., Gasparini F., Lingenhöhl K., Kuhn R., and Koch M. The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethyl)-pyridine (MPEP) blocks fear conditioning in rats. Neuropharmacology 41 (2001) 1-7
41. Simonyi A., Schachtman T.R., and Christoffersen G.R.J. The role of metabotropic glutamate receptor 5 in learning and memory processes. Drug News Perspect 18 (2005) 353-361
42. Simonyi A., Serfozo P., Shelat P.B., Dopheide M.M., Coulibaly A.P., and Schachtman T.R. Differential roles of hippocampal metabotropic glutamate receptors 1 and 5 in inhibitory avoidance learning. Neurobiol Learn Mem 88 (2007) 305-311
43. Spooren W.P., Vassout A., Neijt H.C., Kuhn R., Gasparini F., Roux S., et al. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl) pyridine in rodents. J Pharmacol Exp Therapeutics 295 (2001) 1267-1275
44. Spooren W.P.J.M., Gasparini F., Bergmann R., and Kuhn R. Effects of the prototypical mGlu5 receptor antagonist 2-methyl-6(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats. Eur J Pharmacol 406 (2000) 403-410
45. Steckler T., Oliveira A.F., Van Dyck C., Van Craenendonck H., Mateus A.M., Langlois X., et al. Metabotropic glutamate receptor 1 blockade impairs acquisition and retention in a spatial water maze task. Behav Brain Res 164 (2006) 52-60
46. Tatarczynska E., Klodzinska A., Chojnacka-Wojcik E., Palucha A., Gasparini F., Kuhn R., et al. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br J Pharmacol 132 (2001) 1423-1430
47. Varty G.B., Grilli M., Forlani A., Fredduzzi S., Grzelak M.E., Guthrie D.H., et al. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles. Psychopharmacology 179 (2005) 207-217
48. Wieronska J.M., Smialowska M., Branski P., Gasparini F., Klodzinska A., Szewczyk B., et al. In the amygdala anxiolytic action of mGlu5 receptors antagonist MPEP involves neuropeptide Y but not GABAA signaling. Neuropsychopharmacology 29 (2004) 514-521
49. Zalewska-Winska A., and Wisniewski K. Behavioural activity of S-(3,5)-DHPG, a selective agonist of group 1 metabotropic glutamate receptors. Pharmacol Res 42 (2000) 239-245